Should I invest in Tata Life Sciences & Technology Fund?

We don't give personal investment advice. Tata Life Sciences & Technology Fund - Growth is suitable for an investor whose:understands what asset class this scheme actually invests in (check the factsheet)matches that asset class's volatility profile to their goal horizonCross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 56.3%. 5-year CAGR: 7.53%.

Tata

Tata Life Sciences & Technology Fund - Growth

Returns matrix

Fund return alongside the category average and peer rank for every standard window. Returns under one year are absolute; one year and longer are compound annualised (CAGR).

Window	Fund	Category avg	+/− vs avg	Rank	Quartile
1D	-0.35%	+0.06%	-0.41	226 / 299	Q4
1W	+1.96%	-3.61%	+5.57	47 / 303	Q1
2W	+3.13%	-4.52%	+7.64	41 / 303	Q1
1M	+5.20%	-5.64%	+10.83	46 / 302	Q1
3M	+9.22%	-4.27%	+13.49	55 / 302	Q1
6M	+3.31%	+1.48%	+1.83	152 / 307	Q2
YTD	+12.98%	-0.18%	+13.16	92 / 309	Q2
1Y	+7.38%	+7.10%	+0.28	147 / 307	Q2
2Y	+1.20%	+2.20%	-1.00	171 / 303	Q3
3Y	+7.10%	+0.76%	+6.34	118 / 264	Q2
4Y	+16.68%	+0.58%	+16.10	25 / 235	Q1
5Y	+7.53%	+0.02%	+7.51	80 / 208	Q2
7Y	—	—	—	—	—
10Y	—	—	—	—	—
Inception	+8.30%	+0.51%	+7.78	91 / 310	Q2

Quartile legend: Q1 top 25% Q2 25-50% Q3 50-75% Q4 bottom 25%

Calendar-year returns

Full-year performance vs category average. Current year is partial (year-to-date).

Year	Fund	Category avg	+/− vs avg	Rank
2012 YTD	+12.98%	+23.57%	-10.59	174 / 190
2011	-16.28%	-23.68%	+7.40	44 / 241
2010	+18.15%	+11.69%	+6.46	68 / 256
2009	+120.82%	+65.86%	+54.96	3 / 238
2008	-51.64%	-52.86%	+1.22	62 / 198
2007	+16.20%	+42.91%	-26.71	120 / 137
2006	—	—	—	—

Rolling returns

Removes start-date bias by averaging CAGR over every overlapping N-year window in the fund's history. Higher average plus tight min/max plus high "% positive" = consistent.

1-Year rolling

+16.02%

67 windows

min -50.6% · max 134.5%

58% positive

3-Year rolling

+14.90%

43 windows

min -10.6% · max 37.4%

95% positive

Limited basis — fund is young, so this average may be skewed by which 3Y windows happen to be available.

5-Year rolling

+8.44%

18 windows

min 4.5% · max 15.9%

100% positive

Limited basis — fund is young, so this average may be skewed by which 5Y windows happen to be available.

7-Year rolling

—

Insufficient history

SIP returns — historical "what if"

If you had invested every month in this fund over the chosen period, this is what your investment would be worth today.

Period

Total invested

₹ —

Today's value

₹ —

XIRR

Annualised

Wealth multiplier

Period	Total invested	Today's value	XIRR	Wealth multiplier

XIRR is the annualised internal rate of return on the SIP cash flow — invariant to the monthly amount. "Today's value" and "Total invested" scale linearly with the slider. Past performance does not guarantee future returns. Excludes exit load and taxes.

Risk profile

Risk-adjusted return and volatility, computed from monthly NAV returns over the trailing 3-year and 5-year windows.

Std deviation

13.14%

3-year · annualised

Sharpe ratio

0.12

vs risk-free 6.5%

Sortino ratio

0.19

Downside-only deviation

Max drawdown

-17.35%

Jan 2011 → Dec 2011

% positive months

55.6%

Share of monthly returns > 0 over the 3-year window

Sharpe / Sortino use a risk-free rate of 6.5% (1-year T-bill proxy). Higher Sharpe = more return per unit of total risk; higher Sortino = more return per unit of downside risk.

Recent NAVs

Date	NAV
14 Sep 2012	₹70.1412
13 Sep 2012	₹70.3856
12 Sep 2012	₹70.7665
11 Sep 2012	₹70.3554
10 Sep 2012	₹69.5677
7 Sep 2012	₹68.7953
6 Sep 2012	₹68.4578
5 Sep 2012	₹67.8618
4 Sep 2012	₹68.0100
3 Sep 2012	₹67.8639

Frequently asked questions

These answers are generated from this fund's live metrics — NAV, returns, peer rank, drawdown, SIP backtest. Numbers refresh nightly after AMFI's NAV feed lands.

Tata Life Sciences & Technology Fund - Growth is a Growth from Tata (Unknown plan, Growth option). Latest NAV isn't currently available in our feed — the AMC publishes it once per business day after market close.

Tata Life Sciences & Technology Fund - Growth has NAV history starting from 03 Apr 2006, a track record of about 20 years 2 months. Long-tenured funds like this have weathered multiple market cycles — the 2008 crash, 2013 taper tantrum, 2020 COVID drawdown — which makes their returns more credible than a 3-year track record alone.

Tata Life Sciences & Technology Fund - Growth is managed by Tata. It's classified by AMFI under the 'Growth' SEBI category, which determines its peer set and tax treatment.

Over the trailing 1-year window, Tata Life Sciences & Technology Fund - Growth has delivered a absolute return of 7.38% — +0.28 pp ahead of the Growth category average of 7.10%. The fund ranks #147 of 307 in its category — the second (Q2) quartile.

Over the trailing 3-year window, Tata Life Sciences & Technology Fund - Growth has delivered a CAGR of 7.10% — +6.34 pp ahead of the Growth category average of 0.76%. The fund ranks #118 of 264 in its category — the second (Q2) quartile.

Over the trailing 5-year window, Tata Life Sciences & Technology Fund - Growth has delivered a CAGR of 7.53% — +7.51 pp ahead of the Growth category average of 0.02%. The fund ranks #80 of 208 in its category — the second (Q2) quartile.

₹1 lakh invested in Tata Life Sciences & Technology Fund - Growth exactly 5 years ago would be worth approximately ₹143,733 today — a multiplier of 1.44×, based on the 5-year CAGR of 7.53%. The category average over the same window would have grown ₹1 lakh to ₹100,100.

A ₹10,000 monthly SIP in Tata Life Sciences & Technology Fund - Growth over the last 5 years — total invested ₹600,000 — would be worth ₹823,201 today. That's an XIRR (money-weighted annualised return) of 12.58%.

Tata Life Sciences & Technology Fund - Growth doesn't yet have 10 years of NAVs. Over the longest available window (5-year SIP), ₹10,000/month would have grown to ₹823,201 — XIRR 12.58%.

On a 5-year basis, Tata Life Sciences & Technology Fund - Growth ranks #80 out of 208 funds in the Growth category — that places it in the second quartile (Q2) — above the median. The category average return over the same window is 0.02%; this fund delivered 7.53%.

The worst peak-to-trough decline Tata Life Sciences & Technology Fund - Growth has experienced over the last 5-year window is 56.26% — its NAV fell from a high on 02 Jan 2008 to a low on 09 Mar 2009. Drawdown is a useful gauge of how much short-term pain you'd have endured to capture the long-term return.

Across all 5-year rolling windows, Tata Life Sciences & Technology Fund - Growth averaged 8.44% (best 15.89%, worst 4.51%). 100% of rolling windows ended positive. The 5-year Sharpe ratio is 0.15 — weak risk-adjusted performance.

In calendar year 2011, Tata Life Sciences & Technology Fund - Growth returned -16.28% — beating the Growth category average of -23.68% by 7.40 pp. It ranked #44 of 241 in its category that year.

Tata Life Sciences & Technology Fund - Growth doesn't fit cleanly into the standard Equity/Debt buckets in our taxonomy. Tax treatment depends on actual asset allocation as disclosed by the AMC — check the factsheet or AMFI's classification table.

We don't give personal investment advice. Tata Life Sciences & Technology Fund - Growth is suitable for an investor whose:

understands what asset class this scheme actually invests in (check the factsheet)
matches that asset class's volatility profile to their goal horizon

Cross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 56.3%. 5-year CAGR: 7.53%.

Educational content only — not investment advice. Tax rules summarised above reflect Budget 2024; consult a qualified adviser before transacting.